Archives
-
O-GlcNAcylation in Porcine Oocyte Maturation
2026-09-17
The reference study identifies O-GlcNAcylation as an important regulator of porcine oocyte maturation, linking OGT activity with polar body extrusion, cytoskeletal organization, mitochondrial homeostasis, oxidative stress, and autophagy. Its perturbation-based design provides a useful framework for studying how nutrient-sensitive post-translational modification influences oocyte quality, while also highlighting the need for better mechanistic and translational validation.
-
NHE1, Olfr2, and Macrophage Atherosclerosis
2026-09-17
The reference study identifies macrophage NHE1 as a downstream effector of octanal–Olfr2 signaling in atherosclerosis, connecting calcium-dependent oxidative stress with inflammatory plaque development. Its combined ApoE−/− mouse and RAW264.7 macrophage experiments provide a mechanistic framework for studying NHE1, while also highlighting the need for validation in primary and human systems.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-16
HRP Goat Anti-Mouse IgG (H+L) Antibody, SKU K1221, provides HRP-based detection of mouse-derived primary antibodies in Western blotting, ELISA, IHC, and ICC. It should not be treated as a universal reagent for other host species, live-cell workflows, or unvalidated sorting and purification applications without assay-specific testing.
-
FITC Goat Anti-Mouse IgG: Assay Logic
2026-09-16
The FITC Goat Anti-Mouse IgG (H+L) Antibody supports sensitive mouse IgG detection across imaging and flow cytometry. This article explains how to connect FITC-based readouts with pathway-level conclusions from intestinal epithelial research without confusing signal amplification with mechanistic proof.
-
HRP Goat Anti-Mouse IgG (H+L): Uses
2026-09-15
The Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated reagent K1221 is a polyclonal Horseradish Peroxidase conjugated secondary antibody for detecting mouse IgG in Western blotting, ELISA, IHC, and ICC. Its formulation and storage conditions support reproducible immunodetection when the primary antibody, substrate, and assay controls are appropriately matched.
-
TBST Workflows for uPAR·uPA Assays
2026-09-15
TBST provides a practical, low-background foundation for Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. This workflow-focused guide connects disciplined buffer handling with the conformation-aware uPAR·uPA inhibitor study while clearly separating assay quality from therapeutic efficacy.
-
Gamithromycin PK/PD in a Murine Lung Infection Model
2026-09-14
Yang et al. established an in vivo pharmacokinetic/pharmacodynamic framework for Gamithromycin against Pasteurella multocida in a neutropenic mouse lung infection model. The strong relationship between the unbound 24-hour exposure-to-MIC ratio and antibacterial effect provides quantitative benchmarks for dose optimization while highlighting the limits of transferring murine results directly to cattle.
-
FCCP for Mitochondrial Biology Research
2026-09-14
FCCP converts mitochondrial proton-gradient collapse into a measurable stress test for respiration, ATP dependence, and HIF-linked signaling. This guide pairs practical FCCP workflows with a careful extension to MARCH5-controlled mitochondria-to-peroxisome trafficking, while separating established evidence from assay-planning recommendations.
-
Recombinant Mouse IFN-γ for MASH-HCC Assays
2026-09-13
Recombinant Mouse IFN-γ provides a defined immune stimulus for separating tumor-intrinsic antigen-presentation defects from failures in macrophage or T-cell function. This practical guide translates bile acid–MASH-HCC findings into dose, timing, co-culture, antiviral, and troubleshooting workflows.
-
P. vivax B-Cell Epitopes for Precision Surveillance
2026-09-12
A 2026 study combined computational antigen prioritization, peptide serology, multiplex validation, and conservation analysis to identify immunodominant Plasmodium vivax B-cell epitopes. Four candidates showed strong species-discriminating performance, while one MSP9 epitope provided moderate discrimination of asymptomatic infection, supporting more targeted malaria surveillance.
-
L1023 Anti-Cancer Compound Library for Oncology
2026-09-11
The L1023 Anti-Cancer Compound Library combines 1164 pre-dissolved bioactive compounds for cancer research and high-throughput screening. Its target diversity includes a BRAF kinase inhibitor class, mTOR-directed agents, proteasome inhibitors, deubiquitinase inhibitors, and HDAC inhibitors, while the cited STING study supplies a mechanistic framework for immune-oncology screening.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-11
HRP Goat Anti-Mouse IgG (H+L) Antibody is an affinity-purified, HRP-conjugated secondary reagent for detecting mouse IgG primary antibodies in Western blotting, ELISA, IHC, and ICC. It should not be used as a universal secondary for non-mouse or non-IgG primaries, and assay-specific dilution and incubation conditions require laboratory validation.
-
Bile Acid Retention Drives Immune Escape in MASH-HCC
2026-09-10
A 2026 Cancer Letters study identifies a GPR120–FXR/ABCB11–bile acid–NLRC5 pathway that suppresses MHC-I antigen presentation in MASH-associated hepatocellular carcinoma. Its genetic and pharmacological experiments show that reducing intracellular bile acid retention can restore tumor antigenicity and improve anti-PD-1 responses in mice.
-
TMEM16F in Kupffer Cells Protects Against Listeria
2026-09-10
This study identifies Kupffer-cell TMEM16F, rather than TMEM16F in T or B cells, as a key determinant of liver protection during Listeria monocytogenes infection. Its findings connect plasma-membrane repair and lipid scrambling with control of hepatic inflammation, tissue injury, and metabolic disruption, providing a cell-specific framework for studying infection-associated inflammatory cell death.
-
Aclacinomycin A: From DNA Damage to rDNA Stress
2026-09-09
Aclacinomycin A research extends beyond general cytotoxicity to reveal how topological stress, persistent DNA lesions, and nucleolar compartmentalization can shape assay interpretation. This article connects aclarubicin pharmacology with rDNA damage biology while defining practical controls for apoptosis and DNA damage studies.